亞太地區急性胰臟炎市場預測至 2030 年 - 區域分析 - 按產品、原因和最終用戶

2022年亞太地區急性胰臟炎市值為6.0735億美元，預計2030年將達到10.7606億美元；預計 2022 年至 2030 年CAGR為 7.4%。

急性胰臟炎研發活動和宣傳項目數量激增，推動亞太地區急性胰臟炎市場的發展

全球正在進行廣泛的研究，以調查急性胰臟炎的病因、進展和治療。國家胰臟基金會 (NPF) 提供多項研究資助，每個計畫價值約 5 萬美元。迄今為止，NPF 已為 133 個突破性研究項目提供了超過 500 萬美元的資金。授予為期一年的補助金，用於診斷和/或治療胰臟炎、胰臟癌或小兒胰臟炎。

此外，國際上正在進行一些努力來定義急性胰臟炎的流行病學和病理生理學。因此，針對急性胰臟炎開發有效療法（透過直接和間接手段）的研發活動和宣傳計畫預計將為亞太地區急性胰臟炎市場的公司帶來豐碩成果。

亞太地區急性胰臟炎市場概況

亞太地區急性胰臟炎市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。市場成長歸因於胰臟炎病例增加、研究人員開發胰臟炎治療方法以及政府努力提高民眾意識等因素。此外，與酒精相關的胰臟炎病例也推動了該地區市場的成長。近年來，我國胰臟炎的盛行率呈現上升趨勢。 2022年發表的《1990年至2019年中國胰臟炎負擔及相關危險因子》研究顯示，近年來飲酒已成為我國胰臟炎疾病負擔的重要原因。在中國，酒精性胰臟炎的病例與10年前相比顯著增加。在該國，1990年胰臟炎病例數為380,018例，2019年為493,765例。1990年至2019年，因胰臟炎死亡的總人數也有所增加，1990年為8,976例，2019年為例10,664例。201999年為例。年，胰臟炎死亡人數全國因酒精性胰臟炎死亡3,327.29例，佔胰臟炎死亡總數的31.20%。

亞太地區急性胰臟炎市場收入及 2030 年預測（百萬美元）

亞太地區急性胰臟炎市場細分

亞太地區急性胰臟炎市場按產品、原因、最終用戶和國家進行細分。

根據產品類型，亞太地區急性胰臟炎市場分為藥物、診斷等。 2022年，診斷細分市場佔據最大市場佔有率。

根據方法，亞太地區急性胰臟炎市場分為膽結石、酗酒、遺傳性疾病、感染等。 2022 年，膽結石細分市場佔據最大的市場佔有率。

根據最終用戶，亞太地區急性胰臟炎市場分為醫院、診斷實驗室、門診手術中心等。 2022 年，醫院細分市場佔據最大市場佔有率。

依國家/地區分類，亞太地區急性胰臟炎市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022年，中國主導亞太地區急性胰臟炎市場。

Abbott Laboratories、Baxter International Inc、Boston Scientific Corp、Dynavax Technologies Corp、Fresenius Kabi AG、GE HealthCare Technologies Inc、Koninklijke Philips NV、Medtronic Plc 和 Samsung Healthcare 是亞太地區急性胰臟炎市場上的一些領先公司。

主要市場促進因素
- 急性胰臟炎導致胰臟癌病例增加
- 急性胰臟炎後糖尿病發生率上升
主要市場限制
- 胰臟炎和胰臟癌治療的副作用
主要市場機會
- 急性胰臟炎的研發活動和宣傳項目數量激增
未來的趨勢
- 特異性急性胰臟炎治療的進展
影響分析：

第 6 章：急性胰臟炎市場 - 亞太市場分析

亞太地區急性胰臟炎市場收入，2022 - 2030

第 7 章：亞太地區急性胰臟炎市場 - 收入和 2030 年預測 - 按產品分類

概述
2022 年及 2030 年亞太地區急性胰臟炎市場收入佔有率（按產品分類）（%）
藥物
診斷
其他

第 8 章：亞太地區急性胰臟炎市場 - 收入和 2030 年預測 - 按原因

概述
2022 年和 2030 年亞太地區急性胰臟炎市場收入佔有率（按原因分類）
膽結石
酗酒
遺傳性疾病
感染
其他

第 9 章：亞太地區急性胰臟炎市場 - 收入和 2030 年預測 - 按最終用戶

概述
2022 年及 2030 年亞太地區急性胰臟炎市場收入佔有率（按最終用戶）（%）
醫院
診斷實驗室
門診手術中心
其他

第 10 章：亞太地區急性胰臟炎市場 - 國家分析

概述

第 11 章：亞太地區急性胰臟炎市場-產業格局

概述
亞太地區急性胰臟炎市場的成長策略
無機成長策略
- 概述
有機成長策略
- 概述

第 12 章：公司簡介

Abbott Laboratories
GE HealthCare Technologies Inc
Samsung Healthcare
Koninklijke Philips NV
Baxter International Inc
Dynavax Technologies Corp
Fresenius Kabi AG
Medtronic Plc
Boston Scientific Corp

第 13 章：附錄

Product Code: BMIRE00029216

The Asia Pacific acute pancreatitis market was valued at US$ 607.35 million in 2022 and is expected to reach US$ 1,076.06 million by 2030; it is estimated to grow at a CAGR of 7.4% from 2022 to 2030.

Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis Fuels the Asia Pacific Acute Pancreatitis Market

Extensive research studies are being conducted globally to investigate the etiology, progress, and treatment of acute pancreatitis. The National Pancreas Foundation (NPF) provides multiple research grants worth ~US$ 50,000 per project. To date, the NPF has provided more than US$ 5 million for 133 ground-breaking research projects. A grant is awarded for a period of a year to diagnose and/or treat pancreatitis, pancreatic cancer, or pediatric pancreatitis.

Further, several ongoing international efforts are being made to define the epidemiology and pathophysiology of acute pancreatitis. Thus, R&D activities and awareness programs on acute pancreatitis for the development of effective therapies (through direct and indirect means) are expected to be highly fruitful for companies in the Asia Pacific acute pancreatitis market.

Asia Pacific Acute Pancreatitis Market Overview

The Asia Pacific acute pancreatitis market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth is attributed to factors including rising cases of pancreatitis, researchers to develop a treatment for pancreatitis, and government efforts to raise awareness among the population. In addition, alcohol-related pancreatitis cases also fuel the growth of the market in the region. The prevalence of pancreatitis has shown an upward trend in recent years in China. According to a study titled "Burden of Pancreatitis and associated risk factors in China, 1990 to 2019," published in 2022, alcohol consumption has become an important cause in the disease burden of pancreatitis in recent years in the country. In China, cases of alcoholic pancreatitis are significantly higher compared to 10 years ago. In the country, the number of pancreatitis cases was 380,018 in 1990 and 493,765 in 2019. From 1990 to 2019, the total number of deaths due to pancreatitis also increased, accounting for 8,976 in 1990 and 10,664 in 2019. In 2019, the number of deaths due to alcohol-related pancreatitis was 3,327.29 in the country, accounting for 31.20% of the total deaths due to pancreatitis.

Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Asia Pacific Acute Pancreatitis Market Segmentation

The Asia Pacific acute pancreatitis market is segmented offerings, causes, end user, and country.

Based on offerings, the Asia Pacific acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.

Based on method, the Asia Pacific acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.

Based on end user, the Asia Pacific acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific acute pancreatitis market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific acute pancreatitis market in 2022.

Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the Asia Pacific acute pancreatitis market.

5.1 Key Market Drivers
- 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
- 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
- 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
- 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
- 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:

6. Acute Pancreatitis Market - Asia Pacific Market Analysis

6.1 Asia Pacific Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

7.1 Overview
7.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
- 7.3.1 Overview
- 7.3.2 Medications: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Asia Pacific Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
7.4 Diagnosis
- 7.4.1 Overview
- 7.4.2 Diagnosis: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 Asia Pacific Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

8.1 Overview
8.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
- 8.3.1 Overview
- 8.3.2 Gallstones: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
- 8.4.1 Overview
- 8.4.2 Alcoholism: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
- 8.5.1 Overview
- 8.5.2 Genetic Disorders: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
- 8.6.1 Overview
- 8.6.2 Infections: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Acute Pancreatitis Market - Country Analysis

10.1 Overview

11. Asia Pacific Acute Pancreatitis Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Asia Pacific Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Samsung Healthcare
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Koninklijke Philips NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Dynavax Technologies Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Fresenius Kabi AG
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Boston Scientific Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

List Of Tables

Table 1. Asia Pacific Acute Pancreatitis Market Segmentation
Table 2. Asia Pacific Acute Pancreatitis Market, by Medications - Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Acute Pancreatitis Market, by Diagnosis - Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 6. China: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 7. China: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 8. China: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 11. Japan: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 12. Japan: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. India: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 15. India: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 16. India: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 17. India: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 18. India: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Australia: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 23. Australia: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 24. South Korea: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 25. South Korea: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 28. South Korea: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 34. Recent Inorganic Growth Strategies in the Asia Pacific Acute Pancreatitis Market
Table 35. Recent Organic Growth Strategies in the Asia Pacific Acute Pancreatitis Market
Table 36. Glossary of Terms, Asia Pacific Acute Pancreatitis Market

List Of Figures

Figure 1. Asia Pacific Acute Pancreatitis Market Segmentation, By Country
Figure 2. Asia Pacific Acute Pancreatitis Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Asia Pacific Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
Figure 6. Medications: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Diagnosis: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Asia Pacific Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
Figure 10. Gallstones: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Alcoholism: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disorders: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infections: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 16. Hospitals: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Diagnostic Laboratories: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Centers: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Asia Pacific Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 21. Asia Pacific Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 22. China: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Japan: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. India: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Australia: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. South Korea: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Growth Strategies in the Asia Pacific Acute Pancreatitis Market

亞太地區急性胰臟炎市場預測至 2030 年 - 區域分析 - 按產品、原因和最終用戶

Asia Pacific Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User

目錄

第 1 章：簡介

第 2 章：執行摘要

第 3 章：研究方法

第 4 章：亞太地區急性胰臟炎市場格局

第 5 章：亞太地區急性胰臟炎市場 - 主要產業動態